117 related articles for article (PubMed ID: 1206197)
1. A pharmaceutical perspective of Australia's Health Benefits Program.
Elzarian EJ
J Am Pharm Assoc; 1975 Dec; 15(12):695-8, 708. PubMed ID: 1206197
[No Abstract] [Full Text] [Related]
2. Economics of institutional pharmacy services under national health insurance in Australia.
Brooks GE; Knapp DA
Am J Hosp Pharm; 1975 Oct; 32(10):1018-22. PubMed ID: 1190213
[TBL] [Abstract][Full Text] [Related]
3. Medibank: Australia's new national health insurance program.
Rossiter RJ
Can Med Assoc J; 1976 Feb; 114(4):361, 363-5. PubMed ID: 1253074
[No Abstract] [Full Text] [Related]
4. Medicare Australia and the professional services review scheme.
Bird S
Aust Fam Physician; 2008 Sep; 37(9):757-9. PubMed ID: 18797533
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
Lopert R
Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceuticals in Australia: developments in regulation and governance.
Lofgren H; Boer Rd
Soc Sci Med; 2004 Jun; 58(12):2397-407. PubMed ID: 15081192
[TBL] [Abstract][Full Text] [Related]
7. A perspective on Australia's National Medicines Policy.
Tett SE
Can J Clin Pharmacol; 2004; 11(1):e28-38. PubMed ID: 15226524
[TBL] [Abstract][Full Text] [Related]
8. Providing patient care in community pharmacies in Australia.
Benrimoj SI; Roberts AS
Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Australia's National Medicines Policy using geographical mapping.
Roughead EE; Monteith GR; Harvey KJ; Tett SE
Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical care in community pharmacies: practice and research in Germany.
Eickhoff C; Schulz M
Ann Pharmacother; 2006 Apr; 40(4):729-35. PubMed ID: 16569798
[TBL] [Abstract][Full Text] [Related]
11. Australia's National Health Service.
Meyers D
Br Med J; 1974 Apr; 2(5911):25. PubMed ID: 4825126
[No Abstract] [Full Text] [Related]
12. Pharmaceutical care in community pharmacies: practice and research in Estonia.
Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical benefits scheme policy: confused and tough on patients.
Doran E; Henry D
Intern Med J; 2006 Apr; 36(4):211-3. PubMed ID: 16640735
[No Abstract] [Full Text] [Related]
14. Drug policy down under: Australia's pharmaceutical benefits scheme.
Duckett SJ
Health Care Financ Rev; 2004; 25(3):55-67. PubMed ID: 15229996
[TBL] [Abstract][Full Text] [Related]
15. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
Doran E; Alexander Henry D
J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
[TBL] [Abstract][Full Text] [Related]
16. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
Hamilton C; Lokuge B; Denniss R
Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919
[No Abstract] [Full Text] [Related]
17. Australia's health system.
Power P
World Hosp Health Serv; 2006; 42(3):14-7. PubMed ID: 17249468
[No Abstract] [Full Text] [Related]
18. Australia's new health scheme.
Lloyd N
N Z Med J; 1982 Mar; 95(704):191-2. PubMed ID: 6953351
[No Abstract] [Full Text] [Related]
19. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
Morgan S; McMahon M; Greyson D
Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
[TBL] [Abstract][Full Text] [Related]
20. Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else.
Dalton A
Aust Health Rev; 2001; 24(2):7-14. PubMed ID: 11496474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
